Entrepreneur Briefs

Physicist George Pratt's invention has found its niche, but it didn't happen easily. Pratt, a professor in MIT's department of electrical engineering and computer science, had devised an ultrasound method that could be used to test bone strength. The patented technology was initially licensed to Equine Biomechanics and Exercise Physiology Inc. (Unionville, Pa.) for use in the examination of horses' legs. When that idea fizzled, EQB licensed the technology to businessman Thomas Sherwin, preside

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Physicist George Pratt's invention has found its niche, but it didn't happen easily. Pratt, a professor in MIT's department of electrical engineering and computer science, had devised an ultrasound method that could be used to test bone strength. The patented technology was initially licensed to Equine Biomechanics and Exercise Physiology Inc. (Unionville, Pa.) for use in the examination of horses' legs. When that idea fizzled, EQB licensed the technology to businessman Thomas Sherwin, president of three-year-old Osteo-Technology (Cambridge, Mass.), for applications in the treatment of osteoporosis. By using low-energy sound waves to "stress" bones and measure their resilience, Osteo-Technology has designed a device that could aid in the early detection of osteoporosis. While other types of ultrasound examinations are used in medicine, this application of the technology had not been used with satisfaction in humans before. "We've had to overcome relatively high levels of skepticism," says Sherwin. Apparently they've been ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies